MedTrace Logo

Shift Work, Heredity, Insulin, and Food Timing Study

NCT02997319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2021-05-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether night time eating that coincides with elevated endogenous melatonin impairs glucose tolerance, particularly in carriers of the MTNR1B risk allele.

Conditions

  • Shift Work Type Circadian Rhythm Sleep Disorder
  • Diabetes Mellitus, Type 2
  • Circadian Rhythm Sleep Disorder, Shift Work Type
  • Insulin Resistance

Sponsors & Collaborators

  • Broad Institute of MIT and Harvard

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Richa Saxena, PhD · Massachusetts General Hospital

  • Frank AJL Scheer, PhD · Brigham and Women's Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-24
Primary Completion
2021-05-08
Completion
2021-05-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02997319 on ClinicalTrials.gov